Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001453382 | SCV001657073 | likely benign | Interstitial lung disease 2; Dyskeratosis congenita, autosomal dominant 2 | 2021-06-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004559767 | SCV002633550 | likely benign | Dyskeratosis congenita | 2022-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |